O-GlcNAcomics-Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics

Ronald J. Copeland, Guanghui Han, Gerald Warren Hart

Research output: Contribution to journalArticle

Abstract

O-linked-β-N-acetylglucosamine (O-GlcNAc) is a dynamic PTM of the 3′-hydroxyl groups of serine or threonine residues of nuclear, cytoplasmic, and mitochondrial proteins. The cycling of this modification is regulated in response to nutrients, stress, and other extracellular stimuli by the catalytic activities of O-GlcNAc transferase and O-GlcNAcase. O-GlcNAc is functionally similar to phosphorylation and has been demonstrated to play critical roles in numerous biological processes, including cell signaling, transcription, and disease etiology. Since its discovery nearly 30 years ago, studies have demonstrated that the O-GlcNAc is highly abundant and widespread, like phosphorylation however, the development of methodologies to study O-GlcNAc at the site level has been challenging. Recently, a number of studies have overcome these challenges and describe new tagging, enrichment, and mass spectrometric-based approaches to study O-GlcNAc in terms of its site identification, stoichiometry, and dynamics on proteins. The development of these methods are key for elucidation of O-GlcNAc's functional crosstalk with phosphorylation and other PTMs, and will serve to provide the necessary information for the development of site-specific antibodies, which will aid in the determination of a particular protein's site-specific function. In this review, we describe these methods and summarize results obtained from them demonstrating the roles of O-GlcNAc in diabetes, cancer, Alzheimer's, and in learning and memory, while also describing how these new strategies have implicated O-GlcNAc as a potential diagnostic for the screening of patients for prediabetes.

Original languageEnglish (US)
Pages (from-to)597-606
Number of pages10
JournalProteomics - Clinical Applications
Volume7
Issue number9-10
DOIs
StatePublished - 2013

Fingerprint

Phosphorylation
Pulse time modulation
Cell signaling
Biological Phenomena
Prediabetic State
Acetylglucosamine
Mitochondrial Proteins
Threonine
Transcription
Medical problems
Nuclear Proteins
Crosstalk
Stoichiometry
Hydroxyl Radical
Serine
Nutrients
Catalyst activity
Screening
Proteins
Learning

Keywords

  • Alzheimer's
  • Cancer
  • Diabetes
  • Glycomics
  • O-GlcNAc

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

O-GlcNAcomics-Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics. / Copeland, Ronald J.; Han, Guanghui; Hart, Gerald Warren.

In: Proteomics - Clinical Applications, Vol. 7, No. 9-10, 2013, p. 597-606.

Research output: Contribution to journalArticle

Copeland, Ronald J. ; Han, Guanghui ; Hart, Gerald Warren. / O-GlcNAcomics-Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics. In: Proteomics - Clinical Applications. 2013 ; Vol. 7, No. 9-10. pp. 597-606.
@article{dd9740177ca9453ab07fb380f7d4df80,
title = "O-GlcNAcomics-Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics",
abstract = "O-linked-β-N-acetylglucosamine (O-GlcNAc) is a dynamic PTM of the 3′-hydroxyl groups of serine or threonine residues of nuclear, cytoplasmic, and mitochondrial proteins. The cycling of this modification is regulated in response to nutrients, stress, and other extracellular stimuli by the catalytic activities of O-GlcNAc transferase and O-GlcNAcase. O-GlcNAc is functionally similar to phosphorylation and has been demonstrated to play critical roles in numerous biological processes, including cell signaling, transcription, and disease etiology. Since its discovery nearly 30 years ago, studies have demonstrated that the O-GlcNAc is highly abundant and widespread, like phosphorylation however, the development of methodologies to study O-GlcNAc at the site level has been challenging. Recently, a number of studies have overcome these challenges and describe new tagging, enrichment, and mass spectrometric-based approaches to study O-GlcNAc in terms of its site identification, stoichiometry, and dynamics on proteins. The development of these methods are key for elucidation of O-GlcNAc's functional crosstalk with phosphorylation and other PTMs, and will serve to provide the necessary information for the development of site-specific antibodies, which will aid in the determination of a particular protein's site-specific function. In this review, we describe these methods and summarize results obtained from them demonstrating the roles of O-GlcNAc in diabetes, cancer, Alzheimer's, and in learning and memory, while also describing how these new strategies have implicated O-GlcNAc as a potential diagnostic for the screening of patients for prediabetes.",
keywords = "Alzheimer's, Cancer, Diabetes, Glycomics, O-GlcNAc",
author = "Copeland, {Ronald J.} and Guanghui Han and Hart, {Gerald Warren}",
year = "2013",
doi = "10.1002/prca.201300001",
language = "English (US)",
volume = "7",
pages = "597--606",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley-VCH Verlag",
number = "9-10",

}

TY - JOUR

T1 - O-GlcNAcomics-Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics

AU - Copeland, Ronald J.

AU - Han, Guanghui

AU - Hart, Gerald Warren

PY - 2013

Y1 - 2013

N2 - O-linked-β-N-acetylglucosamine (O-GlcNAc) is a dynamic PTM of the 3′-hydroxyl groups of serine or threonine residues of nuclear, cytoplasmic, and mitochondrial proteins. The cycling of this modification is regulated in response to nutrients, stress, and other extracellular stimuli by the catalytic activities of O-GlcNAc transferase and O-GlcNAcase. O-GlcNAc is functionally similar to phosphorylation and has been demonstrated to play critical roles in numerous biological processes, including cell signaling, transcription, and disease etiology. Since its discovery nearly 30 years ago, studies have demonstrated that the O-GlcNAc is highly abundant and widespread, like phosphorylation however, the development of methodologies to study O-GlcNAc at the site level has been challenging. Recently, a number of studies have overcome these challenges and describe new tagging, enrichment, and mass spectrometric-based approaches to study O-GlcNAc in terms of its site identification, stoichiometry, and dynamics on proteins. The development of these methods are key for elucidation of O-GlcNAc's functional crosstalk with phosphorylation and other PTMs, and will serve to provide the necessary information for the development of site-specific antibodies, which will aid in the determination of a particular protein's site-specific function. In this review, we describe these methods and summarize results obtained from them demonstrating the roles of O-GlcNAc in diabetes, cancer, Alzheimer's, and in learning and memory, while also describing how these new strategies have implicated O-GlcNAc as a potential diagnostic for the screening of patients for prediabetes.

AB - O-linked-β-N-acetylglucosamine (O-GlcNAc) is a dynamic PTM of the 3′-hydroxyl groups of serine or threonine residues of nuclear, cytoplasmic, and mitochondrial proteins. The cycling of this modification is regulated in response to nutrients, stress, and other extracellular stimuli by the catalytic activities of O-GlcNAc transferase and O-GlcNAcase. O-GlcNAc is functionally similar to phosphorylation and has been demonstrated to play critical roles in numerous biological processes, including cell signaling, transcription, and disease etiology. Since its discovery nearly 30 years ago, studies have demonstrated that the O-GlcNAc is highly abundant and widespread, like phosphorylation however, the development of methodologies to study O-GlcNAc at the site level has been challenging. Recently, a number of studies have overcome these challenges and describe new tagging, enrichment, and mass spectrometric-based approaches to study O-GlcNAc in terms of its site identification, stoichiometry, and dynamics on proteins. The development of these methods are key for elucidation of O-GlcNAc's functional crosstalk with phosphorylation and other PTMs, and will serve to provide the necessary information for the development of site-specific antibodies, which will aid in the determination of a particular protein's site-specific function. In this review, we describe these methods and summarize results obtained from them demonstrating the roles of O-GlcNAc in diabetes, cancer, Alzheimer's, and in learning and memory, while also describing how these new strategies have implicated O-GlcNAc as a potential diagnostic for the screening of patients for prediabetes.

KW - Alzheimer's

KW - Cancer

KW - Diabetes

KW - Glycomics

KW - O-GlcNAc

UR - http://www.scopus.com/inward/record.url?scp=84884323220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884323220&partnerID=8YFLogxK

U2 - 10.1002/prca.201300001

DO - 10.1002/prca.201300001

M3 - Article

C2 - 23640805

AN - SCOPUS:84884323220

VL - 7

SP - 597

EP - 606

JO - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 9-10

ER -